SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sellas Life Sciences Q3 Net Loss Widens 49% to $10.09 Million

Sellas Life Sciences Q3 Net Loss Widens 49% to $10.09 Million Sellas Life Sciences’ third-quarte

SLS

Related stories